This review summarizes mechanistic intersections between PD-1/PD-L1 signaling and CAR-T cell biology and discusses emerging synergistic strategies, including multi-target CAR constructs, engineering strategies targeting the TME and tumor metabolism, and localized or self-delivered checkpoint blockade. Here, CD274 is linked to neoplasm.